OncoTargets and Therapy Dove The methylation profiles o PRDM promoters in non ?small cell lung cancer

Tan, SX; Hu, RC; Xia, Q; Tan, YL; Liu, JJ; Gan, GX; Wang, LL

Hu, RC (reprint author), Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Resp Med, 89 Guhan Rd, Changsha 410016, Hunan, Peoples R China.

ONCOTARGETS AND THERAPY, 2018; 11 (): 2991

Abstract

Badcground: Non-small cell lung cancer (NSCLC) is one of the leading malignant tumors worldwide. Aberrant gene promoter methylation contributes to NSC......

Full Text Link